Landscape Capital Management, L.L.C. Biomarin Pharmaceutical Inc Transaction History
Landscape Capital Management, L.L.C.
- $1.14 Billion
- Q2 2025
A detailed history of Landscape Capital Management, L.L.C. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Landscape Capital Management, L.L.C. holds 20,284 shares of BMRN stock, worth $1.09 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
20,284
Previous 9,894
105.01%
Holding current value
$1.09 Million
Previous $699,000
59.51%
% of portfolio
0.1%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
691Shares Held
187MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.22 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$845 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$809 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$658 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.95B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...